COPD Clinical Trial
Official title:
Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test
Verified date | October 2020 |
Source | Laval University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic
obstructive pulmonary disease (COPD). However, this test remains underused in the primary
care. The tools available for its interpretation are little used and the existence of several
decision algorithms can create confusion during the diagnosis.
Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical
practice (interpretation and prescription of spirometry) of family physicians and family
medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval
University.
Secondary objective : To evaluate the usability of SPIRO© among family physicians and
residents in family medicine working in FMU in Quebec affiliated with Laval University.
Methods: This is a pre-post clinical trial with control group. Participants (family MD and
family medicine residents) will be recruited from the various FMU affiliated with Laval
University. Participants working in the FMU in the experimental group will be able to use the
SPIRO® mobile application to facilitate interpretation of the spirometry test results while
participants in the control group will not have access to it during the study. The basic
characteristics of the participants and various behavioral parameters based on the theory of
planned behavior concerning the interpretation and prescription of spirometry test will be
measured. Data from the control group will be collected before those in the experimental
group at the time the application is not yet available, which will minimize contamination
between groups. The data will be collected with questionnaires delivered in person to the
participants before the intervention (T0 time) and then four months later (T1 time) during
their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU
affiliated with Laval University, who will be randomly assigned to two equal groups: control
and experimental. The intervention will consist in sending the SPIRO© mobile application to
participants in the experimental group who will use it for a period of four months.
Status | Completed |
Enrollment | 104 |
Est. completion date | December 20, 2017 |
Est. primary completion date | July 7, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University. Exclusion Criteria: - Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded. |
Country | Name | City | State |
---|---|---|---|
Canada | UMF de Manicouagan | Baie-Comeau | Quebec |
Canada | UMF de Gaspé | Gaspé | Quebec |
Canada | UMF des Etchemins | Lac-Etchemin | Quebec |
Canada | UMF de Lévis | Lévis | Quebec |
Canada | UMF Saint-François d'Assise | Quebec City | Quebec |
Canada | Unité de médecine familiale - GMF Maizerets | Quebec City | Quebec |
Canada | Unité de médecine familiale Laval | Quebec City | Quebec |
Canada | UMF de Trois-Pistoles | Trois-Pistoles | Quebec |
Lead Sponsor | Collaborator |
---|---|
Laval University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Beliefs about capabilities - interpretation | The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry. | six weeks | |
Secondary | Beliefs about consequences - prescription | The beliefs about the consequences of primary care physicians and residents in family medicine regarding prescription of spirometry. | six weeks | |
Secondary | Beliefs about consequences - interpretation | The beliefs about the consequences of primary care physicians and residents in family medicine regarding interpretation of spirometry. | six weeks | |
Secondary | Beliefs about consequences - use of a mobile application | The beliefs about the consequences of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry. | six weeks | |
Secondary | Moral norms - prescription | The beliefs about the moral norms of primary care physicians and residents in family medicine regarding prescription of spirometry. | six weeks | |
Secondary | Moral norms - interpretation | The beliefs about the moral norms of primary care physicians and residents in family medicine regarding interpretation of spirometry. | six weeks | |
Secondary | Moral norms - use of a mobile application | The beliefs about the moral norms of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry. | six weeks | |
Secondary | Intentions - prescription | The beliefs about the intentions of primary care physicians and residents in family medicine regarding prescription of spirometry. | six weeks | |
Secondary | Intentions - interpretation | The beliefs about the intentions of primary care physicians and residents in family medicine regarding interpretation of spirometry. | six weeks | |
Secondary | Intentions - use of a mobile application | The beliefs about the intentions of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry. | six weeks | |
Secondary | Social influence - prescription | The beliefs about the social influence of primary care physicians and residents in family medicine regarding prescription of spirometry. | six weeks | |
Secondary | Social influence - interpretation | The beliefs about the social influence of primary care physicians and residents in family medicine regarding interpretation of spirometry. | six weeks | |
Secondary | Social influence - use of a mobile application | The beliefs about the social influence of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry. | six weeks | |
Secondary | Belief about capabilities - prescription | The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding prescription of spirometry. | six weeks | |
Secondary | Belief about capabilities - use of a mobile application | The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry. | six weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |